Trial Profile
A multicenter, randomized, duoble-blind clinical trial to evaluate the efficacy and safety of GUGUTAMS capsule in patients with benign prostatic hyperplasia
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Tadalafil/tamsulosin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- Acronyms GUGUTAMS IIT
- Sponsors Hanmi Pharmaceutical
- 15 Nov 2018 New trial record